Cefixime Trihydrate API BP/USP/EP

Cefixime Trihydrate is a third-generation oral cephalosporin antibiotic API, used for the treatment of a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, otitis media, and gonorrhea. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Cefixime Trihydrate is typically supplied as a white to off-white crystalline powder and is suitable for use in solid oral dosage forms such as tablets and capsules. The API complies with international pharmacopeial standards (USP/EP/BP) and is manufactured in GMP-certified facilities. Full regulatory support, including Drug Master Files (DMFs) and CTD dossiers, is available for global market registrations.